Trial Profile
Phase III trial of a sustained-release transdermal oxycodone patch
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2013
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Avecho Biotechnology
- 04 Dec 2012 Planned initiation date changed from 1 Mar 2013 to 1 Jun 2013.
- 05 Jun 2012 Planned initiation date changed from 31 Oct 2012 to 1 Mar 2013 as reported in a Phosphagenics media release.
- 22 Nov 2011 New trial record